BI
PFE icon

Beckerman Institutional’s Pfizer PFE Stock Holding History

Beckerman Institutional’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Buy
20,024
+5,607
+39% +$147K 0.23% 89
2026
Q1 		$405K Sell
14,417
-275
-2% -$7.32K 0.22% 90
2025
Q4 		$366K Sell
14,692
-2,845
-16% -$71.7K 0.21% 93
2025
Q3 		$447K Buy
17,537
+93
+0.5% +$2.29K 0.26% 78
2025
Q2 		$423K Sell
17,444
-191
-1% -$4.45K 0.28% 75
2025
Q1 		$447K Buy
17,635
+1,097
+7% +$28.7K 0.32% 72
2024
Q4 		$439K Buy
16,538
+3,540
+27% +$96K 0.35% 70
2024
Q3 		$376K Buy
+12,998
New +$379K 0.32% 70

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Beckerman Institutional's PFE Position: Q2 2026 in Review

Beckerman Institutional increased its Pfizer (PFE) stake by 39% in Q2 2026, buying an estimated $147K and bringing the position to 20,024 shares worth $482K. The position accounts for 0.23% of the portfolio, ranked #89.

Beckerman Institutional first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Beckerman Institutional held 20,024 shares of Pfizer worth $482K as of Q2 2026.
  • Beckerman Institutional bought 5,607 Pfizer shares in Q2 2026, an estimated $147K.
  • Pfizer made up 0.23% of Beckerman Institutional's portfolio in Q2 2026, its #89 holding.
  • Beckerman Institutional first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Beckerman Institutional's 13F filing for Q2 2026, filed 11 Aug 2026.